KR960700729A - 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders) - Google Patents
26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders)Info
- Publication number
- KR960700729A KR960700729A KR1019950703446A KR19950703446A KR960700729A KR 960700729 A KR960700729 A KR 960700729A KR 1019950703446 A KR1019950703446 A KR 1019950703446A KR 19950703446 A KR19950703446 A KR 19950703446A KR 960700729 A KR960700729 A KR 960700729A
- Authority
- KR
- South Korea
- Prior art keywords
- dihydroxycholecalciferol
- hexafluoro
- treatment
- calcium
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2021893A | 1993-02-19 | 1993-02-19 | |
| PCT/US1994/001895 WO1994018985A1 (en) | 1993-02-19 | 1994-02-18 | USE OF 26,26,26,27,27,27-HEXAFLUORO-1α,25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR960700729A true KR960700729A (ko) | 1996-02-24 |
Family
ID=21797387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019950703446A KR960700729A (ko) | 1993-02-19 | 1995-08-17 | 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders) |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US5571802A (ko) |
| EP (1) | EP0684827A1 (ko) |
| JP (1) | JPH08507073A (ko) |
| KR (1) | KR960700729A (ko) |
| AU (2) | AU6247194A (ko) |
| BR (1) | BR9405735A (ko) |
| WO (1) | WO1994018985A1 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004062620A2 (en) * | 2003-01-13 | 2004-07-29 | Cedars-Sinai Medical Center | Paricalcitol as a chemotherapeutic agent |
| AU2014316766B2 (en) * | 2013-09-05 | 2019-10-10 | Waitaki Biosciences | High osteocalcin microcrystalline hydroxyapatite for calcium supplement |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4248791A (en) * | 1980-02-04 | 1981-02-03 | Wisconsin Alumni Research Foundation | 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol |
| US4358406A (en) * | 1981-07-27 | 1982-11-09 | Wisconsin Alumni Research Foundation | 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same |
| US4411833A (en) * | 1982-05-26 | 1983-10-25 | Wisconsin Alumni Research Foundation | Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol |
| JPS60501261A (ja) * | 1983-05-09 | 1985-08-08 | ウイスコンシン アラムナイ リサ−チ フォンデ−ション | １α，２５―ジヒドロキシル化ビタミンＤ↓２化合物及びその製造方法 |
| CA1314872C (en) * | 1986-04-25 | 1993-03-23 | Toshio Nishizawa | Fluorine derivatives of vitamin d _and process for producing the same |
-
1994
- 1994-02-18 AU AU62471/94A patent/AU6247194A/en not_active Abandoned
- 1994-02-18 JP JP6519231A patent/JPH08507073A/ja active Pending
- 1994-02-18 BR BR9405735A patent/BR9405735A/pt not_active Application Discontinuation
- 1994-02-18 WO PCT/US1994/001895 patent/WO1994018985A1/en not_active Application Discontinuation
- 1994-02-18 EP EP94909755A patent/EP0684827A1/en not_active Withdrawn
- 1994-02-18 US US08/199,991 patent/US5571802A/en not_active Expired - Fee Related
-
1995
- 1995-08-17 KR KR1019950703446A patent/KR960700729A/ko not_active Application Discontinuation
-
1998
- 1998-04-06 AU AU60764/98A patent/AU6076498A/en not_active Abandoned
- 1998-08-10 US US09/131,471 patent/US5942502A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5942502A (en) | 1999-08-24 |
| WO1994018985A1 (en) | 1994-09-01 |
| US5571802A (en) | 1996-11-05 |
| BR9405735A (pt) | 1995-12-05 |
| AU6247194A (en) | 1994-09-14 |
| JPH08507073A (ja) | 1996-07-30 |
| AU6076498A (en) | 1998-06-11 |
| EP0684827A1 (en) | 1995-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| HK56897A (en) | Benzocyclobutyl-or indanyl-alkyl-amino-alkyl substituted 3-benzazepin-2-ones useful in the treatment of cardiovascular diseases | |
| ITRM930316A0 (it) | Dina radiografico-chirurgica orientabile per ipianti nelle ossa mascellari. | |
| DE69429905D1 (de) | Puls - Monitor | |
| ZA945545B (en) | Psoriasis treatment | |
| BR9204375A (pt) | Composicao e processo para o tratamento de agua de refrigeracao | |
| HUP9802861A3 (en) | Use of calendula glycosides for the treatment of psoriasis | |
| ZA949294B (en) | Therapeutic substitute guanidines | |
| FI974640A0 (fi) | Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit | |
| AU7384094A (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
| ITMI913465A0 (it) | Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano | |
| KR960700729A (ko) | 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders) | |
| FI952953A0 (fi) | Aineita metabolisten luustosairauksien hoitamiseen | |
| IL89392A0 (en) | Compositions for the treatment of osteoporosis in humans comprising 24,25-dihydroxy-vitamin d3 | |
| ITMI913466A0 (it) | Procedimento per la depurazione dell'1.1.1-trifluoro-2-fluoroetano e dell'1.1.1-trifuoro-2,2-diocloroetano | |
| GB2275191B (en) | Use of antifungal compounds in the treatment of skin disorders | |
| EP0746316A4 (en) | GUANIDINE FOR THERAPEUTIC USE | |
| ITMI931371A1 (it) | Procedimento per la preparazione dell'erdosteina | |
| GB9100970D0 (en) | Acne treatment composition | |
| HU9600725D0 (en) | Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease | |
| FI972637L (fi) | K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon | |
| DE69534740D1 (en) | Analoge des thymosin alpha 1 | |
| ITFI930001A0 (it) | Medicamento per il trattamento dell'asma. | |
| IL106917A0 (en) | Compositions for the treatment of skin disorders | |
| KR940021361U (ko) | 110/220v 겸용 콘센트 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19950817 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19981012 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20000531 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20010228 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20000531 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |